Exploring QSARs of some benzenesulfonamides incorporating cyanoacrylamide moieties as a carbonic anhydrase inhibitors (specifically against tumor-associated isoforms IX and XII)

被引:8
作者
Alafeefy, Ahmed M. [1 ]
Abdel-Aziz, Hatem A. [2 ,3 ]
Carta, F. [4 ,5 ]
Supuran, Claudiu T. [4 ,5 ]
Pathak, Shilendra K. [6 ]
Prasad, Onkar [6 ]
Sinha, Leena [6 ]
机构
[1] Salman Bin Abdulaziz Univ, Coll Pharm, Dept Pharmaceut Chem, Alkharj, Saudi Arabia
[2] King Saud Univ, Coll Pharm, Dept Pharmaceut Chem, Riyadh 11451, Saudi Arabia
[3] Natl Res Ctr, Dept Appl Organ Chem, Cairo, Egypt
[4] Univ Florence, Dept Chem, Polo Sci, Chim Bioorgan Lab, Florence, Italy
[5] Univ Florence, Sect Pharmaceut & Nutriceut Sci, Neurofarba Dept, Florence, Italy
[6] Univ Lucknow, Dept Phys, Lucknow 226007, Uttar Pradesh, India
关键词
Benzenesulfonamides derivatives; carbonic anhydrase isoforms hCA IX and XII; DFT; MLR; QSAR descriptors;
D O I
10.3109/14756366.2014.948435
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Benzenesulfonamides incorporating cyanoacrylamide moieties with activity against tumour-associated human (h) isoforms hCA IX and XII (which are validated antitumor targets) were investigated for their quantitative structural activity relationships (QSAR). Multiple linear regression analysis was used to develop model relationships between molecular descriptors and inhibition constants (K-i). The molecular geometry optimization were performed on all molecules at DFT-B3LYP/6-311++G(d,p) level. Over 1250 molecular descriptors were calculated using Gaussian 09, Hyperchem and EDRAGON programs. Multiple linear regression equations have been developed and validated using leave-one-out cross-validated technique. The derived QSAR models are found to be statistically significant and show good predictive ability.
引用
收藏
页码:519 / 523
页数:5
相关论文
共 29 条
[1]   Carbonic anhydrase inhibitors: Benzenesulfonamides incorporating cyanoacrylamide moieties are low nanomolar/subnanomolar inhibitors of the tumor-associated isoforms IX and XII [J].
Alafeefy, Ahmed M. ;
Isik, Semra ;
Abdel-Aziz, Hatem A. ;
Ashour, Abdelkader E. ;
Vullo, Daniela ;
Al-Jaber, Nabila A. ;
Supuran, Claudiu T. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (06) :1396-1403
[2]   Quinazoline-tyrphostin as a new class of antitumor agents, molecular properties prediction, synthesis and biological testing [J].
Alafeefy, Ahmed M. ;
Alqasoumi, Saleh I. ;
Ashour, Abdelkader E. ;
Masand, Vijay ;
Al-Jaber, Nabila A. ;
Ben Hadda, Taibi ;
Mohamed, Menshawy A. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 53 :133-140
[3]   DENSITY-FUNCTIONAL THERMOCHEMISTRY .3. THE ROLE OF EXACT EXCHANGE [J].
BECKE, AD .
JOURNAL OF CHEMICAL PHYSICS, 1993, 98 (07) :5648-5652
[4]   Anti-infective carbonic anhydrase inhibitors: a patent and literature review [J].
Capasso, Clemente ;
Supuran, Claudiu T. .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2013, 23 (06) :693-704
[5]   A Prodrug Approach Toward Cancer-Related Carbonic Anhydrase Inhibition [J].
Carroux, Cindy J. ;
Rankin, Gregory M. ;
Moeker, Janina ;
Bornaghi, Laurent F. ;
Katneni, Kasiram ;
Morizzi, Julia ;
Charman, Susan A. ;
Vullo, Daniela ;
Supuran, Claudiu T. ;
Poulsen, Sally-Ann .
JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (23) :9623-9634
[6]   Breast Cancer: Reviewing the Past to Give Direction for the Future [J].
Cope, Diane G. .
ONCOLOGY NURSING FORUM, 2013, 40 (05) :425-428
[7]  
Foye OW, 2008, PRINCIPLES MED CHEM
[8]  
Frisch A, 2009, GAUSS VIEWVERSION 5
[9]  
Frisch J., 2009, GAUSSIAN 09W REVISIO
[10]   Perspectives on carbonic anhydrase [J].
Gilmour, K. M. .
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY A-MOLECULAR & INTEGRATIVE PHYSIOLOGY, 2010, 157 (03) :193-197